Novex tris-glycine transfer buffer (25X), dpbs
Ended Awarded
- Contract number
- HHSN26301069
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,063
Award facts
- Contract value 100% obligated
- $3,062.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26301069?
HHSN26301069 was awarded to Life Technologies Corporation by Office of the Director (National Institutes of Health) on February 15, 2012.
How much is contract HHSN26301069 worth?
The government has obligated $3,063 on HHSN26301069.
Is contract HHSN26301069 an order under another contract?
Yes. HHSN26301069 is a BPA call under HHSN263200200056213B, a blanket purchase agreement.
Was contract HHSN26301069 competed?
The extent of competition for HHSN26301069 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award